KR20030026384A - healthful food for diabetic and manufacturing method of the same - Google Patents
healthful food for diabetic and manufacturing method of the same Download PDFInfo
- Publication number
- KR20030026384A KR20030026384A KR1020010056287A KR20010056287A KR20030026384A KR 20030026384 A KR20030026384 A KR 20030026384A KR 1020010056287 A KR1020010056287 A KR 1020010056287A KR 20010056287 A KR20010056287 A KR 20010056287A KR 20030026384 A KR20030026384 A KR 20030026384A
- Authority
- KR
- South Korea
- Prior art keywords
- food
- powder
- ginseng
- diabetic
- health
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 235000013305 food Nutrition 0.000 title abstract description 14
- 206010012601 diabetes mellitus Diseases 0.000 title abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 27
- 241000208340 Araliaceae Species 0.000 claims abstract description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 19
- 235000008434 ginseng Nutrition 0.000 claims abstract description 19
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 235000013373 food additive Nutrition 0.000 claims abstract description 6
- 239000002778 food additive Substances 0.000 claims abstract description 6
- 239000003925 fat Substances 0.000 claims description 18
- 235000013402 health food Nutrition 0.000 claims description 16
- 230000005855 radiation Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000004580 weight loss Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 240000008892 Helianthus tuberosus Species 0.000 abstract 2
- 235000003230 Helianthus tuberosus Nutrition 0.000 abstract 2
- 235000020880 diabetic diet Nutrition 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 9
- 230000037213 diet Effects 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000007901 soft capsule Substances 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 235000020827 calorie restriction Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 150000004043 trisaccharides Chemical class 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000022540 Consciousness disease Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019133 Hangover Diseases 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007937 eating Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- -1 saponin glycosides Chemical class 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000606540 Chione venosa Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 208000002230 Diabetic coma Diseases 0.000 description 1
- 208000013600 Diabetic vascular disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010051295 Neurological infection Diseases 0.000 description 1
- 208000036365 Normal labour Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 241000221037 Pyrularia pubera Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000021149 fatty food Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical group 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Abstract
Description
본 발명은 국화과에 속하는 뚱딴지(돼지감자)와 인삼을 함유한 당뇨병 환자용 건강식품의 제조방법 및 그 제품에 관한 것으로서, 보다 상세하게는 식이요법으로 인한 칼로리 제한에 위배되지 않으면서도 당뇨병자들이 손쉽게 준비하여 섭취할 수 있고 피로회복이나 면역력을 높여 합병증의 유발을 억제하며 섭취 후 포만감을 가질 수 있을 뿐만 아니라 체중 감량은 위한 다이어트에 탁월한 당뇨병 환자용 건강식품의 제조방법 및 그 제품에 관한 것이다.The present invention relates to a method for producing a health food for diabetic patients and their products containing the fat (pork potato) and ginseng belonging to the Asteraceae, more specifically, diabetics easily prepared without violating the calorie restriction due to diet It can be ingested to increase fatigue recovery or immunity to suppress the occurrence of complications and have a feeling of satiety after ingestion, as well as a method for producing a healthy food for diabetics and its products excellent in diet for weight loss.
일반적으로, 당뇨병(糖尿病, diabetes mellitus)은 인슐린량의 부족으로 형액 중의 포도당(혈당)이 정상인보다 그 농도가 높아져서 소변에 포도당이 배출하는 만성질환으로, 발병하는 연령은 중년 이후로서 특히 40∼60대에 많다.In general, diabetes mellitus is a chronic disease in which glucose is excreted in urine due to a lack of insulin, resulting in higher concentrations of glucose (glucose) in the fluid than normal people. There are many.
당뇨병의 초기 주요 증세로는 다뇨(多尿), 갈증, 나른함, 다식(多食), 체중감소 등으로, 이레 따른 합병증으로 신경통, 지각이상, 시력장애 및 피부질환(부스럼, 멍울, 종기, 화농증, 습진) 등이 있고, 이런 당뇨병을 장기간 방치하거나 치료를 적절히 하지 못하면 급격히 악화되어 당뇨병성 아시도시스(acidosis)로 진전되는데, 당뇨병성 아시도시스는 당뇨병성 혼수(昏睡)라고도 하며, 당뇨병의 고혈당으로 인한 의식장애를 말한다.Early major symptoms of diabetes include multiurea, thirst, drowsiness, multi-diet, weight loss, and other complications such as neuralgia, perception, vision disorders and skin disorders (booth, lumps, boils, purulent purpura). Syndrome, eczema) and if left unattended for a long time or inadequately treated, the disease rapidly deteriorates and progresses to diabetic acidosis. Diabetic assidosis is also called diabetic coma, Refers to consciousness disorders.
이것을 일으키는 원인은 부적당한 치료, 특히 인슐린 주사의 중단과 발열, 감염, 수술 등으로 의식장애는 무관심의 정도로부터 혼수에 이르기까지 여러 단계가 있다.The causes of this are inadequate treatment, in particular the interruption of insulin injections, fever, infections, and surgery, and there are several stages of consciousness disorders ranging from indifference to coma.
이런 당뇨병은 조절은 할 수 있지만 완치는 불가능한 것으로, 당뇨병 치료의 목표는 당뇨병의 진행을 정지시킴과 동시에 당뇨병에 빈발하는 합병증(당뇨병성 혈관장애, 신경장애, 감염증)의 발생 및 진전을 예방하는데 있다.Diabetes can be controlled but not cured. The goal of diabetes treatment is to stop the progression of diabetes and to prevent the development and progression of complications (diabetic vascular disorders, neurological disorders, and infections) that are common to diabetes. .
이를 위해 우선 식이요법을 실시하고 그것으로 충분히 조절할 수 없는 경우에는 인슐린 요법, 또는 내복약 치료를 실시한다.To this end, diet is first administered, and if it cannot be controlled sufficiently, insulin therapy or oral medication is administered.
식이요법으로 우선 하루 섭취 칼로리를 정하는데, 체중 1kg당 25kcal, 보통노동은 30∼35kcal, 중노동에는 40∼50kcal로 하는데, 비만인은 다시 칼로리를 제한하여 표준체중에 가깝게 만들 필요가 있다.The diet first determines the calories consumed per day, 25kcal per 1kg body weight, 30-35kcal for normal labor, 40-50kcal for heavy labour, obese people need to be close to the standard weight by limiting calories again.
탄수화물은 하루 150∼300g으로, 쌀밥으로 하면 매일 1∼2공기에 해당하고, 단백질은 성인의 경우 60∼100g, 노동하는 젊은이는 120∼150g이 필요하며, 지방은 총 필요 칼로리에서 탄수화물, 단백질에 의한 칼로리를 뺀 나머지를 섭취하는데 되도록이면 동물성 지방은 피하고 식물성 지방을 많이 취하도록 한다. 이때 체중과다인 사람은 버터, 마가린, 샐러드유, 땅콩과같은 지방성 식품의 섭취를 되도록 피하도록 한다.Carbohydrate is 150 ~ 300g per day, rice is 1 ~ 2 air per day, protein is 60 ~ 100g for adults, 120 ~ 150g for working young people, and fat is needed for carbohydrates and protein. Consume the rest of the calories intake to avoid animal fats, as much as possible to get a lot of vegetable fats. Overweight people should avoid eating fatty foods such as butter, margarine, salad oil, and peanuts.
식사는 하루의 총 칼로리를 결정한 다음 여러 가지 종류의 것을 섭취하는 것이 효과적이다.For meals, it's best to determine your total calories per day and then eat several different types of food.
건강식품(健康食品)이란 보통식품보다 건강의 유지와 증진에 효과가 있거나 그렇게 기대되는 가공식품으로서, 식품이지 약품은 아니며, 그렇다고 식품위생법에 의해 영업허가를 필요로 하는 식품도 아니므로, 행정관청의 감시의 눈이 미치기도 어려워 그 제조나 판매가 방치상태에 놓여 있는 경우가 많다.Health food (健康 食品) is a processed food that is more effective or expected to maintain and promote health than ordinary food. It is a food, not a drug, and it is not a food that requires a business license under the Food Sanitation Law. Surveillance of the eye is also difficult, so the manufacture or sale is often left unattended.
그래서 건강식품을 먹거나 마시거나 하여 설사, 습진, 구토 등을 일으키는 사람도 있어서 불신이나 항의도 높아지고 있는 실정이기 때문에, 그에 대응하기 위해 업계에서는 일부 악질판매업자들 때문에 신용이 있는 건강식품까지도 신용이 떨어질 우려가 있다 하여 자체적으로 실태조사에 나서고 있고 행정당국에서도 식품위생법 등으로 관리하고 있는 실정이다.Therefore, some people cause diarrhea, eczema, and vomiting by eating or drinking health foods, so that distrust and protest are increasing. Due to concerns, the government is conducting a survey on its own and the administrative authorities manage the food hygiene law.
그러나, 이런 시중의 건강식품은 대개 건강한 일반 사람들의 피로회복이나 자양 강장 및 숙취제거 등에 그 목적이 있는 것으로, 이자에서 충분한 양의 인슐린을 공급받지 못해서 생기는 유전적 소질이 있는 당뇨병자들의 치료를 돕고 건강을 살필 수 있는 건강식품은 찾아 볼 수 없는 바, 당뇨병자들은 식이요법만을 꾸준히 하여 섭취하는 칼로리를 제한함으로써 합병증의 유발을 억제할 수밖에 없을 뿐 당뇨병자들의 면역력 강화 등 건강증진을 위한 아무런 건강식품도 제공되지 못하는 문제점이 있었다.However, these health foods are usually for the purpose of restoring fatigue, nourishing tonic and hangover of healthy people, helping to treat diabetic people with genetic predispositions caused by not receiving enough insulin from interest. There is no health food to look for health, diabetics can not only suppress the incidence of complications by limiting the calories consumed by steadily diet, no health food for health promotion, such as strengthening immunity of diabetics There was also a problem that can not be provided.
본 발명은 상기와 같은 문제점들을 해결하기 위한 것으로서, 식이요법으로 인한 칼로리 제한에 위배되지 않으면서도 당뇨병자들이 손쉽게 준비하여 섭취할 수 있고 피로회복이나 면역력을 높여 합병증의 유발을 억제하며 섭취 후 포만감을 가질 수 있을 뿐만 아니라 체중 감량은 위한 다이어트에 탁월한 효과가 있는 당뇨병 환자용 건강식품의 제조방법 및 그 제품을 제공함에 그 목적이 있다.The present invention is to solve the problems as described above, can be easily prepared and ingested by diabetics without violating the calorie restriction due to diet, to suppress the occurrence of complications by increasing fatigue recovery or immunity and feeling full after ingestion In addition to having a weight loss has a purpose to provide a method for producing a health food for diabetics and its products that have an excellent effect on the diet for.
이와 같은 목적을 달성하기 위하여, 본 발명은 인삼과 뚱딴지를 1 : 3.8의 중량비율로 혼합하고 식품첨가제로 허용가능한 담체를 혼합하여 균질화시켜 제조하는 특징이 있다.In order to achieve the above object, the present invention is characterized by producing a homogenized by mixing ginseng and fat in a weight ratio of 1: 3.8 and mixed with an acceptable carrier as a food additive.
또한, 인삼 및 뚱딴지를 각각 세척한 다음, 절단기로 얇게 썰고, 자외선방사로 10∼20분간 살균처리과정을 거치며, 40∼80℃의 온도를 갖는 건조기내에서 20∼60분 정도 건조되고, 다시 분쇄기에 넣어 200메쉬의 분말로 캡슐에 봉입시키는 특징이 있다.In addition, each ginseng and fat was washed, then sliced thinly with a cutting machine, sterilized by ultraviolet radiation for 10 to 20 minutes, dried for 20 to 60 minutes in a dryer having a temperature of 40 to 80 ℃, and again grinder It is characterized by encapsulating it in a capsule of 200 mesh powder.
본 발명을 상세히 설명하면, 본 발명은 인삼과 뚱딴지를 1 : 2∼5, 바람직하게는 1 : 3.8 중량비율로 혼합하여 제조되는 당뇨병 환자용 건강식품의 제조방법 및 그 제품에 관한 것이다.When the present invention is described in detail, the present invention relates to a method for producing a health food for diabetics and a product thereof, which are prepared by mixing ginseng and fat in 1: 2 to 5, preferably 1: 3.8 weight ratio.
본 발명에 의한 건강식품에 함유되어 있는 주성분의 하나인 뚱딴지는 쌍떡잎식물 초롱꽃목 국화과의 여러해살이풀로, 돼지감자라고도 한다. 뚱딴지는 북아메리카가 원산지로, 땅속줄기의 끝이 굵어져서 덩이줄기가 발달한다. 줄기는 곧게 서고가지가 갈라지며 높이가 1.5∼3m이고 센털이 있다. 잎은 줄기 밑 부분에서 마주나고 윗부분에서는 어긋나며 긴 타원 모양이고 끝이 뾰족하며 가장자리에 톱니가 있고 밑 부분이 좁아져 잎자루로 흘러 날개가 된다.Fatty paper, one of the main components contained in the health food according to the present invention, is a perennial herb of the dicotyledon plant Campanula Asteraceae, also called pig potato. Fatty land is native to North America, and the tubers develop due to the thickening of the ends of the underground stems. Stems stand straight, branched, 1.5 ~ 3m high, and have hairs. The leaves face at the bottom of the stem, displaced at the upper part, long oval shape, pointed at the end, sawtooth at the edge, narrowed at the bottom, flowing into the petiole, and wings.
열매는 수과이고, 덩이줄기는 길쭉한 것에서 울퉁불퉁한 것까지 모양이 매우 다양하고 크기와 무게도 다양하다. 덩이줄기 껍질 색깔도 연한 노란색, 갈색, 붉은색, 자주색으로 다양한데, 껍질이 매우 얇아 건조한 공기에 노출하면 금방 주름이 지고 속살이 파삭해진다.Fruits are aquatic, tubers vary in shape from elongated to rugged and vary in size and weight. Tuber shell color also varies from light yellow, brown, red to purple. The skin is so thin that when exposed to dry air, it quickly creases and crusts.
덩이줄기를 식용으로 재배하였으나, 지금은 인가 근처에서 야생으로 자라며 일부에서는 가축의 사료로 쓰기 위해 심기도 한다.Tubers are grown for food, but now they grow wild near permits, and some are planted for livestock feed.
한방에서는 뿌리를 국우(菊芋)라는 약재로 쓰는데, 해열 작용이 있고 대량 출혈을 그치게 한다. 유럽에서는 요리에 넣는 야채로 덩이줄기를 많이 이용한다.In oriental medicine, the root is used as a medicine called gukwoo (菊芋), fever is an action that stops bleeding mass. In Europe, tubers are used as a vegetable for cooking.
본 발명에 의한 건강식품에 함유되어 있는 주성분의 하나인 인삼은 두릅나무과에 속하는 것으로, 파나센, 베타-엘레멘 등의 정유성분과 글루코스, 프록토스 등의 단당류, 수크로스, 말토스 등의 이당류, 트리사카라이드 에이, 트리사카라이드 등의 삼당류, 진세노이드 Rb1, Rb2, Rc, Rd, Rg1, Rg2, Re, Rf 등의 사포닌 배당체류, 베타-시토스테롤, 베타-시토스테릴글루코시드, 파낙시놀, 비타민 비군, 콜린, 등의 성분이 함유되어 있으며, 글루코코르티코이드 분비 촉진작용, 부신피질 기능 강화작용, 대뇌피질 자극에 의한 콜린 작동성 강화작용, 혈압 강하작용, 호흡 촉진작용, 과혈당 억제작용, 인슐린 작용 증강작용, 적혈구 및 헤모글로빈 증가작용, 소화관 운동 항진작용, 단백질 및 디엔에이 합성 촉진작용, 항피로작용, 작업능력증진작용, 성선발육 촉진작용, 중추흥분 및 억제작용, 용혈 방어작용, 항바이러스 작용, 간장 보호작용, 숙취 제거작용, 면역기능 증강작용 등이 있는 것으로 밝혀졌다.Ginseng, which is one of the main ingredients contained in the health food according to the present invention, belongs to the family Arboraceae, and essential oils such as panacene and beta-elemen and monosaccharides such as glucose and fructose, disaccharides such as sucrose and maltose. , Trisaccharides A, trisaccharides such as trisaccharides, saponin glycosides such as ginsenoids Rb1, Rb2, Rc, Rd, Rg1, Rg2, Re, Rf, beta-sitosterol, beta-sitosterylglucoside, par It contains ingredients such as nacinol, vitamin group, choline, etc., and promotes glucocorticoid secretion, adrenal cortex function, strengthens choline function by cerebral cortex stimulation, lowers blood pressure, promotes respiration, and suppresses hyperglycemia. , Enhancing insulin action, increasing red blood cells and hemoglobin, promoting digestive tract movement, promoting protein and DNA synthesis, anti-fatigue, enhancing work capacity, promoting sexual development, It has been found to be excited, such as weight and inhibitory action, hemolytic protective action, antiviral action, the liver protective action, removing hangover effect, immune enhancing effect.
인삼과 뚱딴지(돼지감자)는 깨끗한 물로 세척하고 얇게 썰어 건조기(또는 햇볕에 2∼3일 동안)에 말려 건조한 후 1 : 3.8의 중량비율로 분쇄기에 넣어 미황색의 분말로 제조한다.Ginseng and fat pork (pork potato) are washed with clean water, sliced thinly, dried in a dryer (or 2-3 days in the sun), dried and put into a grinder at a weight ratio of 1: 3.8 to prepare a pale yellow powder.
이때, 사용자의 복용방법은 인삼과 뚱딴지가 1 : 3.8의 중량비울로 혼합된 미황색의 분말을 큰 수푼으로 1수저를 물반컵에 넣고 잘 저은 다음 복용하면 되는데, 성인은 1일 2∼3회 정도로 복용하고, 아이들은 1일 2회 정도로 복용시키면 된다. 특히, 취침 직전에 복용하는 것이 좋다.At this time, the user's way of taking ginseng and obese fat 1: 1, 3.8 weight of yellow powder mixed with a large spoon of water spoon 1 tablespoon in a cup of water and stir well, then take the adult about 2-3 times a day Take it and children should take it twice a day. In particular, it is good to take just before bedtime.
또한, 본 발명 건강식품의 제제형태로는 인삼과 뚱딴지가 1 : 3.8의 중량비율로 된 연질캅셀이나 경구캅셀, 또는 산제, 과립제 정제 등으로 제조할 수 있으며, 연질캅셀이 가장 바람직하다.In addition, as a preparation form of the health food of the present invention, ginseng and obese fat can be prepared in a soft capsule or oral capsule having a weight ratio of 1: 3.8, or powder, granule tablets, etc., and soft capsule is most preferred.
본 발명에 따른 연질캅셀 제형의 건강식품은 통상적인 제조방법에 따라 먼저 인산분말과 뚱딴지 분말을 1 : 3.8의 중량비율로 균질하게 혼합하고, 별도로 팜유, 정제 가공유지, 레시틴, 천연 토코페롤, 대두유 등 식품첨가제로 사용가능한 펌가보조제 붕에서 1종 이상을 균질하게 혼합하고, 이두 혼합물을 균질하게 혼합하여 연질캅셀에 충진함으로써 제조될 수 있다.The health food of the soft capsule formulation according to the present invention is first homogeneously mixed with a phosphate powder and fat powder in a weight ratio of 1: 3.8 according to a conventional manufacturing method, palm oil, refined processed fats, lecithin, natural tocopherol, soybean oil, etc. The perm supplement which can be used as a food additive may be prepared by homogeneously mixing at least one kind, and mixing the two mixtures homogeneously and filling the soft capsule.
본 발명은 다음 실시예를 통하여 구체적으로 설명하나, 다음의 실시예에 의하여 본 발명이 한정되는 것은 아니다.The present invention will be described in detail through the following examples, but the present invention is not limited by the following examples.
실시예 1 : 분말의 제조Example 1 Preparation of Powder
1. 인삼 분말의 제조1. Preparation of Ginseng Powder
인삼 1킬로그램을 정제수로 깨끗이 세척한 다음, 절단기로 0.5∼1mm의 두께로 얇게 썰고 자외선방사로 인한 살균처리과정을 10∼20분 정도 거친 후 40∼80℃의 온도를 갖는 건조기에서 20∼60분 정도 건조시켰다.One kilogram of ginseng is washed with purified water, and then sliced into thin slices of 0.5 to 1 mm with a cutter. After sterilization by UV radiation for 10 to 20 minutes, it is 20 to 60 minutes in a dryer having a temperature of 40 to 80 ° C. It was dried to some extent.
건조된 인삼편을 분쇄기에 넣고 200메쉬의 분말로 대략 520그램의 미립자 분말가루를 얻었다. 이것을 인삼 분말로 사용하였다.The dried ginseng flakes were placed in a grinder to obtain approximately 520 grams of fine powder powder with 200 mesh powder. This was used as ginseng powder.
2. 뚱딴지 분말의 제조2. Preparation of Fat Powder
뚱딴지 1킬로그램을 정제수로 깨끗이 세척한 다음, 절단기로 5∼10mm의 두께로 얇게 썰고 자외선방사로 인한 살균처리과정을 10∼20분 정도 거친 후 40∼80℃의 온도를 갖는 건조기에서 20∼60분 정도 건조시켰다.1 kg of fat is washed with purified water, and then sliced into thin slices of 5 to 10 mm with a cutter, and after 10 to 20 minutes of sterilization due to UV radiation, 20 to 60 minutes in a dryer having a temperature of 40 to 80 ° C. It was dried to some extent.
건조된 뚱딴지를 분쇄기에 넣고 200메쉬의 분말로 대략 150그램의 미립자 분말가루를 얻었다. 이것을 뚱딴지 분말로 사용하였다.The dried fat was placed in a grinder to obtain approximately 150 grams of fine powder of powder of 200 mesh powder. This was used as fat powder.
실시예 2 : 조성물의 제조Example 2 Preparation of Composition
상기한 실시예 1의 방법에 준하여 제조된 인삼 분말과 뚱딴지 분말을 1 : 3.8의 중량비율로 혼합하여 조성물을 제조하였다.The composition was prepared by mixing ginseng powder prepared in accordance with the method of Example 1 and groundfat powder in a weight ratio of 1: 3.8.
이러한 조성물의 성분은 표 1과 같다.The components of this composition are shown in Table 1.
<표 1>TABLE 1
※ 위는 한국 식품 연구소 시험성적임※ Above is test result of Korea Food Research Institute
제제예 1 : 연질캅셀의 제조Formulation Example 1 Preparation of Soft Capsule
본 발명에 의한 건강식품의 조성물 실시예 2를 가지고 통사의 연질캅셀 제조방법으로 제조하였다. 제제예에서 통상 식품제조에 허용되는 식품 첨가제를 사용하여 내용물의 최종 중량을 720mg으로 하였다.The composition of the health food according to the present invention was prepared by the method of manufacturing soft capsules of Example 2 with Example 2. In the formulation example, the final weight of the content was 720 mg using the food additive generally accepted for food manufacture.
인삼 분말 100mgGinseng Powder 100mg
뚱딴지 분말 380mgFat Powder 380mg
팜유(또는 정제가공유지) 20mgPalm oil (or refined common oil) 20mg
레시틴 5mgLecithin 5mg
디-알파-토코페롤 5mgDi-alpha-tocopherol 5mg
대두유 210mgSoybean Oil 210mg
제제예 2 : 경질캅셀제의 제조Formulation Example 2 Preparation of Hard Capsule
본 발명에 의한 건강식품의 조성물 중 실시예 1을 가지고 통상의 경질캅셀 제조방법에 따라 제조하였다. 제제예에서 통상 식품제조에 허용되는 식품 첨가제를 사용하여 과립 또는 산제를 제조한 다음 캅셀에 충진하였다. 내용물의 최종중량은 720mg로 하였다.In Example 1 of the composition of the health food according to the present invention was prepared according to the conventional hard capsule manufacturing method. In the formulation example, granules or powders were prepared using food additives generally acceptable for food preparation, and then filled into capsules. The final weight of the content was 720 mg.
인삼 분말 100mgGinseng Powder 100mg
뚱딴지 분말 380mgFat Powder 380mg
전분 200mgStarch 200mg
유당 40mgLactose 40mg
이와 같은 본 발명은 식이요법으로 인한 칼로리 제한에 위배되지 않으면서도 당뇨병자들이 손쉽게 준비하여 섭취할 수 있고 피로회복이나 면역력을 높여 합병증의 유발을 억제하며 섭취 후 포만감을 가질 수 있을 뿐만 아니라 체중 감량은 위한 다이어트에 탁월한 효과가 있다.The present invention as described above can be easily prepared and consumed by diabetics without violating the calorie restriction caused by the diet, suppression of the occurrence of complications by increasing fatigue recovery or immunity and having a feeling of satiety after ingestion as well as weight loss. There is an excellent effect on diet.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010056287A KR20030026384A (en) | 2001-09-12 | 2001-09-12 | healthful food for diabetic and manufacturing method of the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010056287A KR20030026384A (en) | 2001-09-12 | 2001-09-12 | healthful food for diabetic and manufacturing method of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030026384A true KR20030026384A (en) | 2003-04-03 |
Family
ID=29561899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010056287A KR20030026384A (en) | 2001-09-12 | 2001-09-12 | healthful food for diabetic and manufacturing method of the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20030026384A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060041438A (en) * | 2004-11-09 | 2006-05-12 | 이호운 | Functional food for regulating blood sugar including yerusalem artichoke |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880000017A (en) * | 1986-06-09 | 1988-03-23 | 이상호 | Manufacturing method mainly on fat |
KR890001572A (en) * | 1986-04-28 | 1989-03-27 | 휄렉스 오트 할터 | Remote administration of hyaluronic acid to stray animals |
KR20000005883A (en) * | 1998-06-03 | 2000-01-25 | 박호군 | Health-improving food composition comprising ginseng and citrus peel derivative |
WO2001017379A1 (en) * | 1999-09-03 | 2001-03-15 | Nihon Tohnyo Shokken Co., Ltd. | Drink comprising helianthus tuberosus as the main component and process for producing the same |
-
2001
- 2001-09-12 KR KR1020010056287A patent/KR20030026384A/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890001572A (en) * | 1986-04-28 | 1989-03-27 | 휄렉스 오트 할터 | Remote administration of hyaluronic acid to stray animals |
KR880000017A (en) * | 1986-06-09 | 1988-03-23 | 이상호 | Manufacturing method mainly on fat |
KR20000005883A (en) * | 1998-06-03 | 2000-01-25 | 박호군 | Health-improving food composition comprising ginseng and citrus peel derivative |
WO2001017379A1 (en) * | 1999-09-03 | 2001-03-15 | Nihon Tohnyo Shokken Co., Ltd. | Drink comprising helianthus tuberosus as the main component and process for producing the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060041438A (en) * | 2004-11-09 | 2006-05-12 | 이호운 | Functional food for regulating blood sugar including yerusalem artichoke |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100914065B1 (en) | Natural powdered food using wild flowers and beverage thereof | |
Wolfe | Superfoods: the food and medicine of the future | |
Vaughan et al. | The Oxford book of health foods | |
JP2004159637A (en) | Dietary composition | |
CN110447902B (en) | Composition with weight-losing effect | |
Arshad et al. | Replacement of refined sugar by natural sweeteners: Focus on potential health benefits | |
KR100448260B1 (en) | Processing Methods of Health Food for the Control of Body Weight | |
CN104247734A (en) | Mulberry leaf pineapple cake and making method thereof | |
KR101184666B1 (en) | Composition for improving physiological activity of positive constitution | |
WO2006132042A1 (en) | Nutritional supplement powder and fat for food or medicine | |
KR101632794B1 (en) | METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis | |
KR100707733B1 (en) | Drinking water for a diabetic and manufacturing process thereof | |
Calle et al. | Aroids as underexplored tubers with potential health benefits | |
CN112544767A (en) | Preparation method of selenium-rich tabletted candy | |
KR101033142B1 (en) | Cereal composition for portion packaging with tea and porridge functions and preparation thereof | |
KR101952643B1 (en) | Preparation method of grain noodle | |
KR100503208B1 (en) | Diet-food composition | |
KR101479228B1 (en) | chicken soup | |
Tan et al. | A review on the hypoglycemic properties of selected non-leafy vegetables in Malaysia | |
Murray | The Complete Book of Juicing, Revised and Updated: Your Delicious Guide to Youthful Vitality | |
KR20090019964A (en) | A anti-obesity composition comprising chia seed | |
JP2000166499A (en) | Health food with blended hericium erinaceum | |
KR20030026384A (en) | healthful food for diabetic and manufacturing method of the same | |
Thomas et al. | Chemical Composition of Red Banana (Musa acuminata) Peeled and Unpeeled | |
Arya | Food is your Medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |